During the past decade, National Hospital Organization Saitama National Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Saitama National Hospital" are "Respiratory Syncytial Virus Infections" (1 trials) and "Respiratory Tract Infections" (1 trials). Many other conditions were trialed in "National Hospital Organization Saitama National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Saitama National Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "JNJ-53718678" (1 trials), "Rilematovir" (1 trials) and "Rilematovir X mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Saitama National Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Saitama National Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Hospital Organization Saitama National Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Saitama National Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".